38,126 Shares in Heartflow, Inc. $HTFL Purchased by Lazard Asset Management LLC

Lazard Asset Management LLC bought a new stake in Heartflow, Inc. (NASDAQ:HTFL) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 38,126 shares of the company’s stock, valued at approximately $928,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Caitong International Asset Management Co. Ltd bought a new stake in shares of Heartflow in the 4th quarter worth approximately $27,000. Russell Investments Group Ltd. bought a new position in Heartflow during the fourth quarter valued at $45,000. Legal & General Group Plc purchased a new stake in Heartflow in the third quarter worth $59,000. Strs Ohio purchased a new stake in Heartflow in the fourth quarter worth $99,000. Finally, Police & Firemen s Retirement System of New Jersey bought a new stake in shares of Heartflow in the fourth quarter valued at $131,000.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on HTFL shares. Weiss Ratings downgraded Heartflow from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, July 8th. William Blair started coverage on Heartflow in a research note on Monday, May 4th. They issued an “outperform” rating on the stock. Stifel Nicolaus set a $40.00 target price on shares of Heartflow in a research report on Wednesday, July 15th. Robert W. Baird initiated coverage on shares of Heartflow in a research note on Friday, July 31st. They issued an “outperform” rating and a $34.00 target price for the company. Finally, Canaccord Genuity Group dropped their price target on shares of Heartflow from $43.00 to $37.00 and set a “buy” rating on the stock in a research note on Friday, May 15th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $36.57.

Heartflow Stock Performance

Shares of HTFL opened at $27.17 on Thursday. The stock’s 50-day simple moving average is $28.90 and its 200 day simple moving average is $27.92. The stock has a market capitalization of $2.34 billion and a price-to-earnings ratio of -8.74. Heartflow, Inc. has a 52-week low of $20.13 and a 52-week high of $41.22.

Heartflow (NASDAQ:HTFL) last posted its earnings results on Thursday, May 14th. The company reported ($0.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.08. The company had revenue of $52.59 million for the quarter. The firm’s revenue for the quarter was up 41.3% on a year-over-year basis. On average, research analysts forecast that Heartflow, Inc. will post -0.82 earnings per share for the current fiscal year.

Insider Activity at Heartflow

In related news, CEO John C.M. Farquhar sold 38,900 shares of the company’s stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $35.00, for a total transaction of $1,361,500.00. Following the sale, the chief executive officer owned 457,935 shares of the company’s stock, valued at approximately $16,027,725. This represents a 7.83% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 9,219 shares of the stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $28.34, for a total transaction of $261,266.46. Following the completion of the sale, the insider owned 78,731 shares in the company, valued at $2,231,236.54. This represents a 10.48% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 115,805 shares of company stock valued at $3,548,884. 7.70% of the stock is owned by corporate insiders.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.